Last updated on February 2019

Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma


Brief description of study

The purpose of this study will also assess the safety and tolerability of ANB020 in adult patients with severe eosinophilic asthma.

Detailed Study Description

This is a multi-center, randomized, double-blind, placebo-controlled, proof of concept study to assess the safety and tolerability of ANB20 in adult patients with severe eosinophilic asthma.

Clinical Study Identifier: NCT03469934

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.